The reverse split is a necessary compliance action but the operational turnaround (margin expansion, large contract win, debt reduction) provides a fundamental counter-narrative. Monitor the stock for volatility around the split effective date and watch for Q3 2026 results to confirm margin sustainability and cash burn trajectory toward the stated Q2 2027 profitability target.
Price Chart
Executive Summary
Cycurion announced a 1-for-8 reverse stock split, disclosed a $500,000 share repurchase authorization, and provided an operational update showing gross margin expansion from 6.1% to 29.1% YoY, a $54.6M HHS contract, and a target of break-even profitability by Q2 2027. The reverse split is a compliance step to maintain Nasdaq listing, but the underlying operational improvements are material for a $13M market cap company.
Key Facts
- Announced a 1-for-8 reverse stock split to maintain Nasdaq listing compliance.
- Gross margin expanded from 6.1% in Q2 2025 to 29.1% in Q2 2026.
- Signed a 10-year, $54.6 million award supporting HHS, contributing over $5 million in annual recurring revenue starting November 2026.
- Board authorized a $500,000 share repurchase program.
- Net debt cut by more than half since year-end 2024.
- Targeting break-even, profitability, and a cash-positive operating position by Q2 2027.
- CEO cited a 'manipulation campaign' against the stock and stated the company is pursuing accountability through the courts.
Financial Impact
Gross margin improved from 6.1% to 29.1% YoY; $54.6M HHS contract signed; net debt reduced by more than half since year-end 2024; $500K buyback authorized.
Risk Factors
- Reverse stock splits are often viewed negatively by the market and can lead to selling pressure.
- The company is pre-profitability with a $13M market cap; execution risk on the turnaround is high.
- CEO disclosed a 'manipulation campaign' and ongoing litigation, adding legal and reputational uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-059330 |
| Document: 0001628280-26-059330-index.html | 0001628280-26-059330 |
| Document: 0001628280-26-059330.txt | 0001628280-26-059330 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 8, 2026 24d ago | 8-K | $3.51 $3.36 | ▼ −4.27% | ▼ −3.61% | $3.82 (+8.83%) |
Aug 28, 2026 5w ago | 8-K | $3.85 $3.54 | ▼ −8.05% | ▼ −8.16% | $3.82 (−0.78%) |
Aug 28, 2026 5w ago | 8-K | $3.85 $3.54 | ▼ −8.05% | ▼ −8.16% | $3.82 (−0.78%) |
Aug 26, 2026 5w ago | Press Release | $0.4586 $3.03 | ▼ −560.71% | ▼ −560.83% | $3.82 (−732.97%) |
Aug 26, 2026 5w ago | Press Release | $0.4586 $3.03 | ▲ +560.71% | ▲ +560.83% | $3.82 (+732.97%) |
Aug 19, 2026 6w ago | 8-K | $5.54 $3.67 | ▼ −33.67% | ▼ −33.28% | $3.82 (−31.00%) |
Aug 18, 2026 6w ago | 8-K | $5.54 $3.67 | ▼ −33.67% | ▼ −33.28% | $3.82 (−31.00%) |
Aug 14, 2026 7w ago | 8-K | $0.6850 $0.6539 | ▼ −4.54% | ▼ −3.17% | $3.82 (+457.66%) |
Aug 14, 2026 7w ago | Press Release | $0.6850 $0.6539 | ▼ −4.54% | ▼ −3.17% | $3.82 (+457.66%) |
Aug 12, 2026 7w ago | 8-K | $4.96 $5.54 | ▲ +11.61% | ▲ +12.06% | $3.82 (−22.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access